Why the EpiPen Has a Monopoly (Hint: It’s Not “Runaway Capitalism”)
By Micah J. Fleck The news has once again rolled around that the EpiPen, a specific brand of epinephrine auto-injector, has risen in price astronomically – far beyond the normal rate of inflation. Most recently, the company behind the EpiPen, Mylan, has reportedly raised their price from $100 to $500 per pack – right…